Literature DB >> 17890917

Basal cell carcinoma with matrical differentiation: expression of beta-catenin [corrected] and osteopontin.

Rachele Del Sordo1, Antonio Cavaliere, Angelo Sidoni.   

Abstract

Basal cell carcinoma with matrical differentiation is an extremely rare variant. To date, only 12 cases have been described in the literature. This tumor is a typical basal cell carcinoma with basaloid nests containing shadow cells identical to those of pilomatricoma and pilomatrical carcinoma. We present two additional cases and have investigated the immunoprofile of .-catenin and osteopontin with the aim of determining both their biological significance and possible diagnostic utility. The morphological and immunohistochemical features of these cases that we have found suggest that basal cell carcinomas with matrical differentiation belong to a spectrum of lesions deriving from hair follicles in which .-catenin plays an important role in the tumor development, differentiation, and behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890917     DOI: 10.1097/DAD.0b013e318156dceb

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Nasal Basal Cell Carcinoma with Matrical Differentiation: Risk of Metastasis and Impact on Management.

Authors:  Christopher Maroun; Elie Alam; Ibrahim Khalifeh; Ossama Abbas; Roger V Moukarbel
Journal:  Head Neck Pathol       Date:  2016-06-15

2.  Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

Authors:  Zhiyong Mi; Hongtao Guo; Paul C Kuo
Journal:  BMC Res Notes       Date:  2009-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.